Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Zepbound (tirzepatide): This week's injectable treatment works by targeting GLP-1 and GIP receptors, offering the utmost weight loss efficiency recorded in clinical trials
Whilst some patients may worry about potential cognitive effects, current clinical evidence and UK regulatory data do not identify memory impairment as a recognised adverse effect of this medication class
By influencing brain pathways that control hunger and reward, semaglutide helps individuals naturally eat less and make healthier food choices
To further investigate the bill and see the full legislation that passed the Senate, please check out some of our other resources
Medical Writing Assistance The authors acknowledge the medical writing assistance of Caroline Freeman of Oxford PharmaGenesis, Oxford, UK (funded by Novo Nordisk A/S)
